- Home
- AEI vs HOTH Comparison
AEI vs HOTH Comparison
Compare AEI & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEI
- HOTH
- Stock Information
- Founded
- AEI 2014
- HOTH 2017
- Country
- AEI United States
- HOTH United States
- Employees
- AEI N/A
- HOTH N/A
- Industry
- AEI Building operators
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- AEI Real Estate
- HOTH Health Care
- Exchange
- AEI Nasdaq
- HOTH Nasdaq
- Market Cap
- AEI 13.6M
- HOTH 15.6M
- IPO Year
- AEI N/A
- HOTH 2019
- Fundamental
- Price
- AEI $1.26
- HOTH $1.29
- Analyst Decision
- AEI
- HOTH Strong Buy
- Analyst Count
- AEI 0
- HOTH 3
- Target Price
- AEI N/A
- HOTH $4.00
- AVG Volume (30 Days)
- AEI 67.9K
- HOTH 302.2K
- Earning Date
- AEI 08-26-2025
- HOTH 08-12-2025
- Dividend Yield
- AEI N/A
- HOTH N/A
- EPS Growth
- AEI N/A
- HOTH N/A
- EPS
- AEI N/A
- HOTH N/A
- Revenue
- AEI $16,069,911.00
- HOTH N/A
- Revenue This Year
- AEI N/A
- HOTH N/A
- Revenue Next Year
- AEI N/A
- HOTH N/A
- P/E Ratio
- AEI N/A
- HOTH N/A
- Revenue Growth
- AEI 74.28
- HOTH N/A
- 52 Week Low
- AEI $0.70
- HOTH $0.59
- 52 Week High
- AEI $2.61
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- AEI 53.83
- HOTH 49.92
- Support Level
- AEI $1.16
- HOTH $1.14
- Resistance Level
- AEI $1.23
- HOTH $1.32
- Average True Range (ATR)
- AEI 0.08
- HOTH 0.09
- MACD
- AEI -0.01
- HOTH -0.01
- Stochastic Oscillator
- AEI 41.18
- HOTH 53.11
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).